These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2906579)

  • 41. Efficacy of sulphasalazine plus methotrexate in rheumatoid arthritis.
    Islam MN; Alam MN; Haq SA; Moyenuzzaman M; Patwary MI; Rahman MH
    Bangladesh Med Res Counc Bull; 2000 Apr; 26(1):1-7. PubMed ID: 11192489
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sulphasalazine desensitisation in patients with arthritis.
    McCarthy C; Coughlan R
    Ir J Med Sci; 1994 May; 163(5):238-9. PubMed ID: 7913919
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
    Woolacott N; Bravo Vergel Y; Hawkins N; Kainth A; Khadjesari Z; Misso K; Light K; Asseburg C; Palmer S; Claxton K; Bruce I; Sculpher M; Riemsma R
    Health Technol Assess; 2006 Sep; 10(31):iii-iv, xiii-xvi, 1-239. PubMed ID: 16948890
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulating cytokine levels in patients with rheumatoid arthritis: results of a double blind trial with sulphasalazine.
    Danis VA; Franic GM; Rathjen DA; Laurent RM; Brooks PM
    Ann Rheum Dis; 1992 Aug; 51(8):946-50. PubMed ID: 1358037
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Methotrexate and sulphasalazine as combination therapy in rheumatoid arthritis.
    Nisar M; Carlisle L; Amos RS
    Br J Rheumatol; 1994 Jul; 33(7):651-4. PubMed ID: 7912633
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical efficacy of sulphasalazine--a review.
    Capell HA
    Br J Rheumatol; 1995 Nov; 34 Suppl 2():35-9. PubMed ID: 8535647
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Sulphasalazine-induced lupus in psoriatic arthritis.
    Veale DJ; Ho M; Morley KD
    Br J Rheumatol; 1995 Apr; 34(4):383-4. PubMed ID: 7788157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine.
    Scott DL; Smolen JS; Kalden JR; van de Putte LB; Larsen A; Kvien TK; Schattenkirchner M; Nash P; Oed C; Loew-Friedrich I;
    Ann Rheum Dis; 2001 Oct; 60(10):913-23. PubMed ID: 11557646
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sulfasalazine therapy in psoriatic arthritis: clinical and immunologic response.
    Newman ED; Perruquet JL; Harrington TM
    J Rheumatol; 1991 Sep; 18(9):1379-82. PubMed ID: 1684619
    [TBL] [Abstract][Full Text] [Related]  

  • 50. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
    Tobin AM; Kirby B
    BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sulphasalazine. An alternative drug for second-line treatment of juvenile chronic arthritis.
    Varbanova BB; Dyankov ED
    Adv Exp Med Biol; 1999; 455():331-6. PubMed ID: 10599365
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of two etanercept regimens for treatment of psoriasis and psoriatic arthritis: PRESTA randomised double blind multicentre trial.
    Sterry W; Ortonne JP; Kirkham B; Brocq O; Robertson D; Pedersen RD; Estojak J; Molta CT; Freundlich B
    BMJ; 2010 Feb; 340():c147. PubMed ID: 20124563
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A study to determine the active moiety of sulphasalazine in rheumatoid arthritis.
    Neumann VC; Taggart AJ; Le Gallez P; Astbury C; Hill J; Bird HA
    J Rheumatol; 1986 Apr; 13(2):285-7. PubMed ID: 2873245
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of sulphasalazine on the radiological progression of rheumatoid arthritis.
    Pullar T; Hunter JA; Capell HA
    Ann Rheum Dis; 1987 May; 46(5):398-402. PubMed ID: 2884932
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [How to choose a basic drug for psoriatic arthritis?].
    Koó E; Seszták M; Gyulai F; Farkas V
    Orv Hetil; 1991 Dec; 132(49):2709-12, 2715-6. PubMed ID: 1684842
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neutropenia in patients with inflammatory arthritis treated with sulphasalazine.
    Farr M; Symmons DP; Blake DR; Bacon PA
    Ann Rheum Dis; 1986 Sep; 45(9):761-4. PubMed ID: 2876683
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low dose desensitisation does not reduce the toxicity of sulphasalazine in rheumatoid arthritis.
    McInnes IB; Porter D; Murphy EA; Thomson EA; Madhok R; Hunter JA; Pullar T; Capell HA
    Ann Rheum Dis; 1996 May; 55(5):328-30. PubMed ID: 8660109
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sulphasalazine alone or in combination with D-penicillamine in rheumatoid arthritis.
    Taggart AJ; Hill J; Astbury C; Dixon JS; Bird HA; Wright V
    Br J Rheumatol; 1987 Feb; 26(1):32-6. PubMed ID: 2880632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sulphasalazine in the treatment of pauciarticular-onset juvenile chronic arthritis.
    Gedalia A; Barash J; Press J; Buskila D
    Clin Rheumatol; 1993 Dec; 12(4):511-4. PubMed ID: 7907286
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).
    Ramiro S; Radner H; van der Heijde D; van Tubergen A; Buchbinder R; Aletaha D; Landewé RB
    Cochrane Database Syst Rev; 2011 Oct; (10):CD008886. PubMed ID: 21975788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.